181 related articles for article (PubMed ID: 30053437)
1. The von Hippel Lindau tumour suppressor gene is a novel target of E2F4-mediated transcriptional repression in preeclampsia.
Alahari S; Garcia J; Post M; Caniggia I
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3298-3308. PubMed ID: 30053437
[TBL] [Abstract][Full Text] [Related]
2. Compromised JMJD6 Histone Demethylase Activity Affects VHL Gene Repression in Preeclampsia.
Alahari S; Post M; Rolfo A; Weksberg R; Caniggia I
J Clin Endocrinol Metab; 2018 Apr; 103(4):1545-1557. PubMed ID: 29373688
[TBL] [Abstract][Full Text] [Related]
3. Expression of von Hippel Lindau (pVHL) protein in placentae from normal pregnant women and women with preeclampsia.
Rajakumar A; Doty K; Daftary A; Markovic N; Conrad KP
Placenta; 2006; 27(4-5):411-21. PubMed ID: 15955559
[TBL] [Abstract][Full Text] [Related]
4. Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone disease.
Hatzimichael E; Dranitsaris G; Dasoula A; Benetatos L; Stebbing J; Crook T; Bourantas KL
Clin Lymphoma Myeloma; 2009 Jun; 9(3):239-42. PubMed ID: 19525194
[TBL] [Abstract][Full Text] [Related]
5. Early- and late-onset preeclampsia and the DNA methylation of circadian clock and clock-controlled genes in placental and newborn tissues.
van den Berg CB; Chaves I; Herzog EM; Willemsen SP; van der Horst GTJ; Steegers-Theunissen RPM
Chronobiol Int; 2017; 34(7):921-932. PubMed ID: 28613964
[TBL] [Abstract][Full Text] [Related]
6. The von Hippel-Lindau (VHL) tumor-suppressor gene is down-regulated by selenium deficiency in Caco-2 cells and rat colon mucosa.
Uthus E; Begaye A; Ross S; Zeng H
Biol Trace Elem Res; 2011 Aug; 142(2):223-31. PubMed ID: 20632125
[TBL] [Abstract][Full Text] [Related]
7. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma.
To KK; Zhan Z; Bates SE
Mol Cell Biol; 2006 Nov; 26(22):8572-85. PubMed ID: 16954373
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the HLA-G promoter is associated with preeclampsia.
Tang Y; Liu H; Li H; Peng T; Gu W; Li X
Mol Hum Reprod; 2015 Sep; 21(9):736-44. PubMed ID: 26116450
[TBL] [Abstract][Full Text] [Related]
9. Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma.
Luu VD; Boysen G; Struckmann K; Casagrande S; von Teichman A; Wild PJ; Sulser T; Schraml P; Moch H
Clin Cancer Res; 2009 May; 15(10):3297-304. PubMed ID: 19401348
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of placental gene expression in transcriptional subtypes of preeclampsia.
Leavey K; Wilson SL; Bainbridge SA; Robinson WP; Cox BJ
Clin Epigenetics; 2018; 10():28. PubMed ID: 29507646
[TBL] [Abstract][Full Text] [Related]
11. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
[TBL] [Abstract][Full Text] [Related]
12. Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter.
Zatyka M; Morrissey C; Kuzmin I; Lerman MI; Latif F; Richards FM; Maher ER
J Med Genet; 2002 Jul; 39(7):463-72. PubMed ID: 12114475
[TBL] [Abstract][Full Text] [Related]
13. [Ginsenoside 20(S)-Rg3 upregulates tumor suppressor VHL gene expression by suppressing DNMT3A-mediated promoter methylation in ovarian cancer cells].
Wang L; Han X; Zheng X; Zhou Y; Hou H; Chen W; Li X; Zhao L
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):100-106. PubMed ID: 33509760
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.
Perier A; Fregni G; Wittnebel S; Gad S; Allard M; Gervois N; Escudier B; Azzarone B; Caignard A
Oncogene; 2011 Jun; 30(23):2622-32. PubMed ID: 21258414
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer.
Banks RE; Tirukonda P; Taylor C; Hornigold N; Astuti D; Cohen D; Maher ER; Stanley AJ; Harnden P; Joyce A; Knowles M; Selby PJ
Cancer Res; 2006 Feb; 66(4):2000-11. PubMed ID: 16488999
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
17. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
18. No evidence for DNA methylation of von Hippel-Lindau ubiquitin ligase complex genes in breast cancer.
Huang KT; Dobrovic A; Fox SB
Breast Cancer Res Treat; 2010 Dec; 124(3):853-6. PubMed ID: 20680678
[TBL] [Abstract][Full Text] [Related]
19. Analysis of aberrant methylation of the VHL gene by transgenes, monochromosome transfer, and cell fusion.
Kuzmin I; Geil L; Ge H; Bengtsson U; Duh FM; Stanbridge EJ; Lerman MI
Oncogene; 1999 Oct; 18(41):5672-9. PubMed ID: 10523847
[TBL] [Abstract][Full Text] [Related]
20. Dynamic HIF1A regulation during human placental development.
Ietta F; Wu Y; Winter J; Xu J; Wang J; Post M; Caniggia I
Biol Reprod; 2006 Jul; 75(1):112-21. PubMed ID: 16611863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
